Business Wire

FiscalNote Acquires EU Regulatory Intelligence Leader Shungham

Jaa

FiscalNote, the Washington, D.C.-based company that dramatically improves the way organizations engage with government, today announced at the World Economic Forum in Switzerland, its acquisition of Brussels-based Shungham, a provider of systematic regulatory and legislative intelligence about European Union issues through its flagship product “EU Issue Tracker”. The move expands FiscalNote’s international leadership in the government relationship management (GRM) sector where it already provides data on regulatory and legislative issues for EU Member States and more than 20 countries worldwide. As one of the largest companies in the global market, the combined organization will provide the most comprehensive legislative and regulatory data and workflows for the EU and its Member States.

Founded in 2010 with a strong reputation for the highly-structured analysis and subject matter expertise EU regulatory issues require, Shungham’s EU Issue Tracker helps major global brands including Coca-Cola, L’Oreal, Nestle, Siemens, and BMW better understand potential regulation as it is being developed. With the most comprehensive data and analysis in a market where automated intelligence is difficult due to differing reporting requirements by country, Shungham provides a critical edge to its clients in strategic regulatory intelligence and compliance.

“As the changes in the global political landscape are giving rise to new and evolving needs in political advocacy, our clients have been asking for more actionable intelligence about the EU and its member states, along with other strategic global regions,” said Tim Hwang, co-founder and CEO of FiscalNote and a WEF Technology Pioneer. “Shungham adds a much needed human element to our AI-powered intelligence that will give our clients more insight into legislative and regulatory issues at all stages of development. As we focus at the World Economic Forum about making connections in an evolving world, this deal will empower organizations worldwide to be more effective in their engagements with government and stay aware of global updates.”

FiscalNote created the GRM category nearly two years ago with the first comprehensive engagement platform, services, and mobile application. The platform now includes data from 20 countries, and expects to rapidly expand across the world in 2018 in the hopes of one day reaching every country in the world. Shungham is the second acquisition announced in the last six months as FiscalNote attempts to grow its global presence and capabilities for its customers.

“As Brexit nears, there is a rapidly growing need for strategic intelligence on both the EU and its Members States among our clients, and joining FiscalNote gives us the ability to rapidly scale our human-curation approach and apply automation for the first time,” said Michel Ehrlich, CEO of Shungham. “The combination of our depth of intelligence in this market along with FiscalNote’s collaboration and issues management tools will allow our clients to more easily take strategic action on issues that affect their business.”

About FiscalNote

FiscalNote is a leading technology innovator at the intersection of global business & government. With offices in DC, NYC, Baton Rouge, Seoul, India, and Brussels, the company has raised more than $43 million from prominent early-stage investors including Renren, First Round Capital’s Dorm Room Fund, Green Visor Capital, MoneyToday, Visionnaire Ventures, Perle Ventures, 645 Ventures, Steve Case, Mark Cuban and Jerry Yang/AME Cloud Ventures. FiscalNote has grown to become one of the largest privately held companies in the legal analytics space, powering 21.9 million users and 1,300 law firms, legal departments and governments across its platforms. FiscalNote is revolutionizing access to legislation, regulations and court cases for organizations around the world. Organizations — from small startups and non-profits to multinational corporations — that rely on FiscalNote’s revolutionary government relationship management (GRM) and grassroots advocacy solutions include Cargill, Toyota, Intel, Johnson & Johnson, the Pharmaceutical Care Management Association, Microsoft, PhRMA, Salesforce, the Consumer Technology Association, Anthem BlueCross BlueShield, Schlumberger, Macy’s, and the National Education Association.

FiscalNote is a World Economic Forum Technology Pioneer.

Contact information

Julie Walsh, Finn Partners
202-518-6489
Julie.Walsh@FinnPartners.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Maxion Wheels to Showcase Market-Leading Light Weight Commercial Vehicle Wheels at REIFEN 201816.8.2018 07:05Tiedote

Maxion Wheels, the world’s largest producer of wheels, announced today its participation in REIFEN, the leading tire and wheel industry event in Europe, from Sept. 11 – 15, 2018 in Hall 12.1 / Stand D24. For the first time, REIFEN will be co-located with Automechanika Frankfurt at the Messe Frankfurt. “REIFEN is the premier event for European tire and wheel manufacturers and resellers, bringing us together to meet and collaborate on the important aftermarket themes of innovation, service and delivery,” stated Mark Gerardts, Vice President of Global Sales and Marketing, Maxion Wheels. “After a highly popular launch to truck and trailer OEMs in 2017, we’re excited to have the industry’s lightest mass production steel wheel now available to our aftermarket distributors. This wheel, along with several others, including our new 10.00W-20 wide base tubetype and tubeless heavy duty armored vehicles wheel are great examples of our continued efforts to bring our OE multi-application innovations

Lenovo Accelerates Turnaround with Back-to-Back, Double-Digit Quarterly Revenue Growth16.8.2018 02:40Tiedote

Lenovo Group (HKSE: 0992) (PINK SHEETS: LNVGY) today announced results for its first fiscal quarter ended June 30, 2018. For the second straight quarter, Lenovo achieved strong double-digit growth in revenue year-on-year. Group revenue reached US$11.91 billion, up 19% year-on-year. The company also reported strong pre-tax income during the quarter of US$113 million, an improvement of US$182 million year-on-year, as profitability improved across all businesses. In the first fiscal quarter, Lenovo’s profit attributable to equity holders grew to US$77 million, up US$149 million year-over-year. Basic earnings per share in the first fiscal quarter was 0.65 US cents or 5.10 HK cents. “As we persistently execute our 3-wave strategy, all our businesses made solid improvements in both revenue and profitability. Lenovo has passed the turning point and entered a phase of ‘acceleration’ - accelerating the execution of our transformation strategy and accelerating the rising momentum in business per

CORRECTING and REPLACING Ebola Successfully Neutralized by Latest Generation Polyclonal Immunotherapy16.8.2018 01:37Tiedote

Please replace the release with the following corrected version due to multiple revisions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180815005602/en/ New Ebola immunotherapy developed by SAB Biotherapeutics uses natural human polyclonal antibodies to combat disease. (Photo: SAB Biotherapeutics) The corrected release reads: EBOLA SUCCESSFULLY NEUTRALIZED BY LATEST GENERATION POLYCLONAL IMMUNOTHERAPY Promising new platform can rapidly respond to emerging infectious diseases Sioux Falls, SD, August 15, 2018 – SAB Biotherapeutics, Inc. (SAB), a clinical-stage biopharmaceutical company, today announced that its anti-Ebola immunotherapy (SAB-139) provided “100% protection against a lethal dose of the Ebola virus” in a recent animal study published in The Journal of Infectious Diseases . The study was conducted at the Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of He

QConnect – Markkinoiden älykkäin, erittäin kompakti ja lujatekoinen viestintälaite15.8.2018 23:23Tiedote

Quake Global, Inc. (QUAKE), yksi maailman johtavista IoT-markkinoiden toimittajista, julkaisi QConnect™, uuden sukupolven kehittyneen telematiikkalaitteen. Äärimmäisen kompakti QConnect integroituu kiinteisiin ja liikkuviin omaisuuksiin niiden seuraamiseksi, valvomiseksi ja hallitsemiseksi reaaliajassa mistä ja milloin tahansa. Laite tarjoaa useita pitkälle kehitettyjä langattomia kommunikaatiovaihtoehtoja, mukaan lukien LTE/2G/3G, kaksitaajuus-Wi-Fi, Bluetooth/BLE, V2X ja satelliitti. Laite on suunniteltu vastaamaan moniin eri vaatimuksiin yksinkertaisista ja edullisista seurantasovelluksista aina korkean suorituskyvyn monikanavaisiin videon suoratoistosovelluksiin. Tämä lehdistötiedote sisältää multimediaa. Katso koko julkaisu täällä: https://www.businesswire.com/news/home/20180815005706/fi/ Quake Global’s new QConnect, the most intelligent, global, ultra-compact and rugged communication device available (Photo: Business Wire) QConnect tarjoaa joustavuutta sen ainutlaatuisilla sovell

Ebola Successfully Neutralized by Latest Generation Polyclonal Immunotherapy15.8.2018 20:43Tiedote

SAB Biotherapeutics, Inc. (SAB), a clinical-stage biopharmaceutical company, today announced that its anti-Ebola immunotherapy (SAB-139) provided “100% protection against a lethal dose of the Ebola virus” in a recent animal study published in The Journal of Infectious Diseases . The study was conducted by the National Interagency Confederation for Biological Research and other collaborators including United States Army Medical Research Institute of Infectious Diseases (USAMRIID) and the Naval Medical Research Center (NMRC). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180815005602/en/ New Ebola immunotherapy developed by SAB Biotherapeutics uses natural human polyclonal antibodies to combat disease. (Photo: SAB Biotherapeutics) According to the World Health Organization, Ebola virus disease (EVD), formerly known as Ebola hemorrhagic fever, is a severe, often fatal illness in humans with an average fatality rate around 50%.

Rimini Street Receives Asia-Pacific Stevie Award for Customer Service Innovation15.8.2018 20:05Tiedote

Rimini Street, Inc. (Nasdaq: RMNI), a global provider of enterprise software products and services, and the leading third-party support provider for Oracle and SAP software products, today announced it has been honored with a Stevie® Award in the Innovation in Customer Service Management, Planning & Practice category for its ultra-responsive, premium level service in the Asia-Pacific region. This honor marks the Company’s 12th Stevie Award win this year, and the second consecutive year the Company has been recognized by the Asia-Pacific Stevie Awards. Rimini Street recently earned Stevie Awards in several categories, including Company of the Year from the 2018 American Business Awards® and Customer Service Department of the Year from the 2018 Stevie Awards for Sales & Customer Service. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180815005580/en/ Rimini Street Receives Asia-Pacific Stevie Award for Customer Service Innovat

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme